» Articles » PMID: 2537457

Muscarinic Receptor Regulation of Cytoplasmic Ca2+ Concentrations in Human SK-N-SH Neuroblastoma Cells: Ca2+ Requirements for Phospholipase C Activation

Overview
Journal Mol Pharmacol
Date 1989 Feb 1
PMID 2537457
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

The relationship between muscarinic receptor-mediated inositol lipid hydrolysis and the generation of Ca2+ signals has been examined in human SK-N-SH neuroblastoma cells. The resting cytoplasmic calcium concentration [( Ca2+]i) as determined by fura-2 fluorescence measurements was 59 +/- 2 nM. Upon the addition of oxotremorine-M, there was a 4-fold increase in [Ca2+]i (293 +/- 18 nM), with half-maximal stimulation obtained at an agonist concentration of 8 microM, a value similar to that previously observed for the enhancement of phosphoinositide hydrolysis. Addition of partial muscarinic agonists for phosphoinositide turnover (bethanechol, oxo-2, and arecoline) elicited correspondingly smaller increases in [Ca2+]i than did oxotremorine-M. Inclusion of EGTA lowered the basal [Ca2+]i within 2 min and markedly reduced (greater than 60%) the magnitude of the agonist-induced rise in [Ca2+]i. Addition of muscarinic agonists to SK-N-SH cells that had been prelabeled with [3H]inositol led to the rapid (5-15 sec) release of inositol mono-, bis-, and triphosphates. When assayed under conditions similar to those employed for the fluorescence measurements, EGTA also inhibited both the basal and oxotremorine-M-stimulated release of inositol phosphates by 45-61%. Conversely, ionomycin both elevated [Ca2+]i and stimulated the release of inositol phosphates. The addition of Ca2+ (10 nM-2 microM) to digitonin-permeabilized cells directly stimulated the release of labeled inositol mono-, bis-, and trisphosphates by 3-4-fold with a half-maximal effect (EC50) observed at 145 nM free Ca2+ (Ca2+f). A further (6-fold) calcium-dependent increase in inositol phosphate release was obtained by inclusion of either guanosine-5-O-(3-thio)-trisphosphate (GTP gamma S) or oxotremorine-M. In the combined presence of agonist and GTP gamma S, a synergistic release of all three inositol phosphates occurred, with half-maximal stimulation observed at 35-40 nM Ca2+f, a value similar to the [Ca2+]i in quiescent cells. These results indicate (i) that the magnitude of the initial rise in [Ca2+]i is directly related to the production of phosphoinositide-derived second messenger molecules and (ii) that the phospholipase C-mediated breakdown of inositol lipids in SK-N-SH cells is particularly sensitive to regulation by physiologically relevant Ca2+ concentrations. It is concluded that, in SK-N-SH cells, either an elevation above or reduction below basal [Ca2+]i can modulate the extent of hydrolysis of inositol lipids and the subsequent generation of calcium signals.

Citing Articles

An in vitro paradigm for diabetic cerebral oedema and its therapy: a critical role for taurine and water channels.

Koves I, Russo V, Higgins S, Mishra A, Pitt J, Cameron F Neurochem Res. 2011; 37(1):182-92.

PMID: 21935730 DOI: 10.1007/s11064-011-0598-8.


Ca2+ entry following P2X receptor activation induces IP3 receptor-mediated Ca2+ release in myocytes from small renal arteries.

Povstyan O, Harhun M, Gordienko D Br J Pharmacol. 2010; 162(7):1618-38.

PMID: 21175582 PMC: 3057298. DOI: 10.1111/j.1476-5381.2010.01169.x.


Imaging decreased brain docosahexaenoic acid metabolism and signaling in iPLA(2)β (VIA)-deficient mice.

Basselin M, Rosa A, Ramadan E, Cheon Y, Chang L, Chen M J Lipid Res. 2010; 51(11):3166-73.

PMID: 20686114 PMC: 2952557. DOI: 10.1194/jlr.M008334.


Muscarinic receptor stimulation of D-aspartate uptake into human SH-SY5Y neuroblastoma cells is attenuated by hypoosmolarity.

Foster D, Heacock A, Fisher S J Pharmacol Exp Ther. 2010; 333(1):297-309.

PMID: 20080957 PMC: 2846019. DOI: 10.1124/jpet.109.164277.


Intracellular- and extracellular-derived Ca(2+) influence phospholipase A(2)-mediated fatty acid release from brain phospholipids.

Rosa A, Rapoport S Biochim Biophys Acta. 2009; 1791(8):697-705.

PMID: 19327408 PMC: 2735787. DOI: 10.1016/j.bbalip.2009.03.009.